Literature DB >> 29934885

Pulmonary arterial stiffness assessed by cardiovascular magnetic resonance imaging is a predictor of mild pulmonary arterial hypertension.

Jordan C Ray1,2, Charles Burger3,2, Patricia Mergo4,2, Robert Safford1,2, Joseph Blackshear1,2, Christopher Austin1,2, DeLisa Fairweather1,2, Michael G Heckman5,2, Tonya Zeiger3,2, Marcia Dubin5,2, Brian Shapiro6,7.   

Abstract

Early detection of mild pulmonary arterial hypertension (PAH) based on clinical evaluation and echocardiography remains quite challenging. In addition to enhanced right ventricular (RV) assessment, cardiac magnetic resonance (CMR) imaging may accurately reflect deleterious remodeling and increased stiffness of the central pulmonary arteries based on pulsatility, or percent change of the PA during the cardiac cycle. The purpose of this study is to assess the utility of measuring PA pulsatility by CMR as a potential early maker in PAH. We hypothesize that pulsatility may help discriminate mild PAH from normal control subjects. Consecutive patients with PAH (n = 51) were prospectively enrolled to receive same day CMR and right heart catheterization (RHC). PA stiffness indices including pulsatility, distensibility, compliance, and capacitance were calculated. Comparisons were made between patients with varying severities of PAH and normal controls (n = 18). Of the 51 subjects, 20 had mild PAH, and 31 moderate-severe based on hemodynamic criteria. PA pulsatility demonstrated a progressive decline from normal controls (53%), mild PAH (22%), to moderate-severe PAH (17%; p < 0.001). There was no difference in RV size, function or mass between mild PAH and normal controls. PA pulsatility below 40% had an excellent ability to discriminate between mild PAH and normal controls with a sensitivity of 95% and specificity of 94%. CMR assessment of PA stiffness may noninvasively detect adverse pulmonary vascular remodeling and mild PAH, and thus be a valuable tool for early detection of PAH. Trial Registration: ClinicalTrials.gov Identifier: NCT01451255; https://clinicaltrials.gov/ct2/show/NCT01451255 .

Entities:  

Keywords:  Magnetic resonance imaging; Pulmonary artery pulsatility; Pulmonary hypertension

Mesh:

Year:  2018        PMID: 29934885     DOI: 10.1007/s10554-018-1397-y

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  44 in total

1.  Pulmonary vascular volume, resistance, and compliance in man.

Authors:  W R MILNOR; A D JOSE; C J MCGAFF
Journal:  Circulation       Date:  1960-07       Impact factor: 29.690

Review 2.  ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents.

Authors:  W Gregory Hundley; David A Bluemke; J Paul Finn; Scott D Flamm; Mark A Fogel; Matthias G Friedrich; Vincent B Ho; Michael Jerosch-Herold; Christopher M Kramer; Warren J Manning; Manesh Patel; Gerald M Pohost; Arthur E Stillman; Richard D White; Pamela K Woodard
Journal:  J Am Coll Cardiol       Date:  2010-06-08       Impact factor: 24.094

3.  Cardiac magnetic resonance imaging-derived pulmonary artery distensibility index correlates with pulmonary artery stiffness and predicts functional capacity in patients with pulmonary arterial hypertension.

Authors:  Ki-Woon Kang; Hyuk-Jae Chang; Young-Jin Kim; Byoung-Wook Choi; Hye Sun Lee; Woo-In Yang; Chi-Young Shim; Jongwon Ha; Namsik Chung
Journal:  Circ J       Date:  2011-07-15       Impact factor: 2.993

4.  Evaluation of pulmonary artery stiffness in pulmonary hypertension with cardiac magnetic resonance.

Authors:  Javier Sanz; Mbabazi Kariisa; Santo Dellegrottaglie; Susanna Prat-González; Mario J Garcia; Valentin Fuster; Sanjay Rajagopalan
Journal:  JACC Cardiovasc Imaging       Date:  2009-03

5.  Accuracy of Doppler echocardiography in the hemodynamic assessment of pulmonary hypertension.

Authors:  Micah R Fisher; Paul R Forfia; Elzbieta Chamera; Traci Housten-Harris; Hunter C Champion; Reda E Girgis; Mary C Corretti; Paul M Hassoun
Journal:  Am J Respir Crit Care Med       Date:  2009-01-22       Impact factor: 21.405

Review 6.  Updated clinical classification of pulmonary hypertension.

Authors:  Gerald Simonneau; Michael A Gatzoulis; Ian Adatia; David Celermajer; Chris Denton; Ardeschir Ghofrani; Miguel Angel Gomez Sanchez; R Krishna Kumar; Michael Landzberg; Roberto F Machado; Horst Olschewski; Ivan M Robbins; Rogiero Souza
Journal:  J Am Coll Cardiol       Date:  2013-12-24       Impact factor: 24.094

7.  Pulmonary arterial pulse wave velocity and impedance in man.

Authors:  W R Milnor; C R Conti; K B Lewis; M F O'Rourke
Journal:  Circ Res       Date:  1969-12       Impact factor: 17.367

8.  Quantification of right ventricular afterload in patients with and without pulmonary hypertension.

Authors:  Jan-Willem Lankhaar; Nico Westerhof; Theo J C Faes; Koen M J Marques; J Tim Marcus; Piet E Postmus; Anton Vonk-Noordegraaf
Journal:  Am J Physiol Heart Circ Physiol       Date:  2006-05-12       Impact factor: 4.733

9.  Screening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines.

Authors:  Michael McGoon; David Gutterman; Virginia Steen; Robin Barst; Douglas C McCrory; Terry A Fortin; James E Loyd
Journal:  Chest       Date:  2004-07       Impact factor: 9.410

Review 10.  Relevant issues in the pathology and pathobiology of pulmonary hypertension.

Authors:  Rubin M Tuder; Stephen L Archer; Peter Dorfmüller; Serpil C Erzurum; Christophe Guignabert; Evangelos Michelakis; Marlene Rabinovitch; Ralph Schermuly; Kurt R Stenmark; Nicholas W Morrell
Journal:  J Am Coll Cardiol       Date:  2013-12-24       Impact factor: 24.094

View more
  6 in total

1.  Cardiovascular imaging 2019 in the International Journal of Cardiovascular Imaging.

Authors:  Johan H C Reiber; Gabriel T R Pereira; Luis A P Dallan; Hiram G Bezerra; Johan De Sutter; Arthur E Stillman; Nico R L Van de Veire; Joachim Lotz
Journal:  Int J Cardiovasc Imaging       Date:  2020-05       Impact factor: 2.357

Review 2.  Cardiac Magnetic Resonance in Pulmonary Hypertension-an Update.

Authors:  Samer Alabed; Pankaj Garg; Christopher S Johns; Faisal Alandejani; Yousef Shahin; Krit Dwivedi; Hamza Zafar; James M Wild; David G Kiely; Andrew J Swift
Journal:  Curr Cardiovasc Imaging Rep       Date:  2020-11-07

3.  Patient-Specific Computational Analysis of Hemodynamics and Wall Mechanics and Their Interactions in Pulmonary Arterial Hypertension.

Authors:  Byron A Zambrano; Nathan McLean; Xiaodan Zhao; Ju-Le Tan; Liang Zhong; C Alberto Figueroa; Lik Chuan Lee; Seungik Baek
Journal:  Front Bioeng Biotechnol       Date:  2021-01-28

Review 4.  State-of-the-art MR Imaging for Thoracic Diseases.

Authors:  Yumi Tanaka; Yoshiharu Ohno; Satomu Hanamatsu; Yuki Obama; Takahiro Ueda; Hirotaka Ikeda; Akiyoshi Iwase; Takashi Fukuba; Hidekazu Hattori; Kazuhiro Murayama; Takeshi Yoshikawa; Daisuke Takenaka; Hisanobu Koyama; Hiroshi Toyama
Journal:  Magn Reson Med Sci       Date:  2021-04-29       Impact factor: 2.760

5.  Ventricular mass discriminates pulmonary arterial hypertension as redefined at the Sixth World Symposium on Pulmonary Hypertension.

Authors:  Catherine E Simpson; Todd M Kolb; Steven Hsu; Stefan L Zimmerman; Celia P Corona-Villalobos; Stephen C Mathai; Rachel L Damico; Paul M Hassoun
Journal:  Pulm Circ       Date:  2022-01-18       Impact factor: 2.886

6.  Metabolic Syndrome Mediates ROS-miR-193b-NFYA-Dependent Downregulation of Soluble Guanylate Cyclase and Contributes to Exercise-Induced Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction.

Authors:  Taijyu Satoh; Longfei Wang; Cristina Espinosa-Diez; Bing Wang; Scott A Hahn; Kentaro Noda; Elizabeth R Rochon; Matthew R Dent; Andrea R Levine; Jeffrey J Baust; Samuel Wyman; Yijen L Wu; Georgios A Triantafyllou; Ying Tang; Mike Reynolds; Sruti Shiva; Cynthia St Hilaire; Delphine Gomez; Dmitry A Goncharov; Elena A Goncharova; Stephen Y Chan; Adam C Straub; Yen-Chun Lai; Charles F McTiernan; Mark T Gladwin
Journal:  Circulation       Date:  2021-06-23       Impact factor: 39.918

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.